IGF1 and obesity disorder: Although in the literature the total serum levels of IGF1 does not appear to decrease in obesity, and, on the contrary, levels of bioactive IGF1 are even slightly elevated when compared to normal weighting subjects, in populations affected by steatosis and steatohepatitis this picture changes.